Paranovus Entertainment Technology Ltd. (PAVS) is up 628.3% today. Here is some analysis on what might have caused this price movement.
Analysis: The most identifiable catalyst is a June 9 prospectus supplement that registers an at-the-market (ATM) program of up to about $195 million, which appears to have drawn heavy retail attention and outsized trading activity. Given the company’s very small reported share count before the ATM, the move also looks consistent with a momentum/low-float squeeze dynamic rather than a fundamental revaluation.
Details:
Sources:
U.S. Securities and Exchange Commission (SEC), StockTitan, ChartExchange
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$PAVS Hedge Fund Activity
We have seen 1 institutional investors add shares of $PAVS stock to their portfolio, and 7 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RENAISSANCE TECHNOLOGIES LLC removed 19,989 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $34,580
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 14,732 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $25,486
- UBS GROUP AG removed 861 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,833
- SBI SECURITIES CO., LTD. removed 57 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $98
- AMERITAS INVESTMENT PARTNERS, INC. removed 37 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $64
- CITADEL ADVISORS LLC removed 9 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $15
- TOWER RESEARCH CAPITAL LLC (TRC) added 5 shares (+inf%) to their portfolio in Q1 2026, for an estimated $10
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.